Serous carcinoma of the ovary: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 7: | Line 7: | ||
| Micro = | | Micro = | ||
| Subtypes = | | Subtypes = | ||
| LMDDx = [[serous carcinoma]] from other sites, [[clear cell carcinoma of the ovary]], poorly differentiated [[endometrioid carcinoma of the ovary]], [[ovarian serous borderline tumour]] for low-grade tumours | | LMDDx = [[serous carcinoma]] from other sites (e.g. [[serous carcinoma of the fallopian tube]]), [[clear cell carcinoma of the ovary]], poorly differentiated [[endometrioid carcinoma of the ovary]], [[ovarian serous borderline tumour]] for low-grade tumours | ||
| Stains = | | Stains = | ||
| IHC = WT-1 +ve, CK7 +ve, ER +ve, HNF-1beta -ve | | IHC = WT-1 +ve, CK7 +ve, ER +ve, [[HNF-1beta]] -ve | ||
| EM = | | EM = | ||
| Molecular = +/-BRCA1 mutation, +/-BRCA2 mutation | | Molecular = +/-BRCA1 mutation, +/-BRCA2 mutation | ||
| Line 153: | Line 153: | ||
*[[Ovary]]. | *[[Ovary]]. | ||
*[[Ovarian tumours]]. | *[[Ovarian tumours]]. | ||
*[[Serous carcinoma of the fallopian tube]]. | |||
==References== | ==References== | ||